This inventor holds 1 USPTO granted patent. Top assignees: American Cyanamid Company, Whitehead Institute for Biomedical Research. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1999
Title: The Innovations of Raul Andino
Introduction
Raul Andino is a prominent inventor based in New York, NY (US). He is known for his significant contributions to the field of viral vaccines. His innovative work has led to the development of groundbreaking technologies that have the potential to impact public health.
Latest Patents
Raul Andino holds a patent for "Replication-competent recombinant viral vaccines and method of producing." This patent involves replication-competent recombinant viruses, particularly replication-competent recombinant polioviruses. These viruses include exogenous nucleic acid sequences that encode an exogenous polypeptide and a nucleic acid sequence that encodes an artificial proteolytic cleavage site. This technology allows for the cleavage of the precursor protein produced by the parent virus, resulting in the release of the exogenous polypeptide. The recombinant viruses are useful as vaccines against various infections, including bacterial, viral, fungal, and yeast infections, as well as parasitic diseases, cancer, and allergies. Raul Andino has 1 patent to his name.
Career Highlights
Throughout his career, Raul Andino has worked with esteemed organizations such as the Whitehead Institute for Biomedical Research and American Cyanamid Company. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Raul Andino has collaborated with notable colleagues, including Mark B Feinberg and Carolyn L Weeks-Levy. These partnerships have further enriched his research and innovation efforts.
Conclusion
Raul Andino's contributions to the field of viral vaccines demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of research in combating infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile